Insmed Incorporated
INSM
$132.17
$3.853.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 107.42M | 92.82M | 104.44M | 93.43M | 90.34M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 107.42M | 92.82M | 104.44M | 93.43M | 90.34M |
| Cost of Revenue | 28.08M | 21.28M | 26.15M | 21.17M | 20.96M |
| Gross Profit | 79.34M | 71.55M | 78.29M | 72.26M | 69.38M |
| SG&A Expenses | 154.76M | 147.55M | 142.52M | 118.93M | 106.57M |
| Depreciation & Amortization | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 361.29M | 322.66M | 349.66M | 292.17M | 275.54M |
| Operating Income | -253.88M | -229.84M | -245.21M | -198.75M | -185.20M |
| Income Before Tax | -320.44M | -255.67M | -234.28M | -219.51M | -299.77M |
| Income Tax Expenses | 1.24M | 912.00K | 1.27M | 1.01M | 838.00K |
| Earnings from Continuing Operations | -321.69M | -256.58M | -235.55M | -220.52M | -300.61M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -321.69M | -256.58M | -235.55M | -220.52M | -300.61M |
| EBIT | -253.88M | -229.84M | -245.21M | -198.75M | -185.20M |
| EBITDA | -250.66M | -227.23M | -243.01M | -196.56M | -183.04M |
| EPS Basic | -1.70 | -1.42 | -1.32 | -1.27 | -1.94 |
| Normalized Basic EPS | -0.86 | -0.82 | -0.87 | -0.74 | -0.79 |
| EPS Diluted | -1.70 | -1.42 | -1.32 | -1.27 | -1.94 |
| Normalized Diluted EPS | -0.86 | -0.82 | -0.87 | -0.74 | -0.79 |
| Average Basic Shares Outstanding | 189.30M | 180.86M | 179.02M | 173.72M | 154.70M |
| Average Diluted Shares Outstanding | 189.30M | 180.86M | 179.02M | 173.72M | 154.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |